American Association for the Advancement of Science, Science Translational Medicine, 464(10), 2018
DOI: 10.1126/scitranslmed.aat3487
Full text: Unavailable
DKK3 is produced by the stroma in pancreatic cancer, promotes tumor progression and resistance to therapy, and is a therapeutic target.